home / stock / vtyx / vtyx articles


VTYX Articles, Ventyx Biosciences Inc. - From 10/10/23

Stock Information

Company Name: Ventyx Biosciences Inc.
Stock Symbol: VTYX
Market: NASDAQ
Website: ventyxbio.com

Menu

VTYX VTYX Quote VTYX Short VTYX News VTYX Articles VTYX Message Board
Get VTYX Alerts

News, Short Squeeze, Breakout and More Instantly...

Crude Oil Moves Lower; Neogen Posts Downbeat Results | Benzinga

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 175 points on Tuesday. The Dow traded up 0.53% to 33,781.59 ...

Why Startek Shares Are Trading Higher By 29%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session | Benzinga

Gainers SuperCom Ltd. (NASDAQ: SPCB) shares jumped 89% to $0.6805, after falling 13% on Monday. SMX (Security Matters) Public Limited Company (NAS...

S&P 500 Rises 1%; US Wholesale Inventories Fall In August | Benzinga

U.S. stocks traded higher midway through trading, with the Dow Jones gaining over 250 points on Tuesday. The Dow traded up 0.81% to 33,876.62 while...

PagerDuty, John Wiley & Sons, Ventyx Biosciences And Other Big Stocks Moving Lower On Tuesday | Benzinga

U.S. stocks traded higher, with the Dow Jones gaining around 150 points on Tuesday. Here are some big stocks recording losses in today’s sess...

Why Ventyx Biosciences Stock Fell After-Hours | Benzinga

Ventyx Biosciences, Inc. (NASDAQ: VTYX) shares plunged in Monday's after-hours session after the company announced results from the Phase 2 tri...

Ventyx Biosciences Chief Scientific Officer Acquires 10,000 Shares After Exercising Company Stock Options | Benzinga

John Nuss, Chief Scientific Officer at Ventyx Biosciences (NASDAQ:VTYX), reported a large exercise of company stock options on October 4, according...

Chief Business Officer at Ventyx Biosciences Exercises Options Worth $424K | Benzinga

Christopher Krueger, Chief Business Officer at Ventyx Biosciences (NASDAQ:VTYX), reported a large exercise of company stock options on October 4, a...

Ventyx Biosciences Recent Insider Activity | Benzinga

Martin Auster, Chief Financial Officer at Ventyx Biosciences (NASDAQ:VTYX), reported a large insider sell on September 7, according to a new SEC fi...

Previous 10 Next 10